Related Experiment Video

Updated: May 8, 2026

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals
11:09

High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals

Published on: December 16, 2022

What can we learn about valvular heart disease from PET/CT?

William S A Jenkins1, Calvin Chin, James H F Rudd

  • 1Centre for Cardiovascular Science, University of Edinburgh, Little France Crescent, Edinburgh, UK.

Future Cardiology
|September 12, 2013
PubMed

Insights

Positron emission tomography/computed tomography (PET/CT) shows promise for diagnosing and managing valvular heart disease, particularly calcific aortic stenosis and infective endocarditis, with evolving techniques and novel tracers improving patient outlook.

Area of Science:

  • Cardiovascular Imaging
  • Nuclear Medicine
  • Radiochemistry

Background:

  • Valvular heart disease (VHD) is a significant cause of illness and death, with increasing prevalence due to an aging population.
  • Current diagnostic and management strategies for VHD require enhancement to improve patient outcomes.

Purpose of the Study:

  • To review the current and future applications of positron emission tomography/computed tomography (PET/CT) in valvular heart disease.
  • To highlight the role of PET/CT in specific conditions like calcific aortic stenosis and infective endocarditis.
  • To discuss the potential of novel radiotracers in advancing VHD management.

Main Methods:

  • Review of existing literature on PET/CT applications in VHD.
  • Analysis of early data using established radiotracers for VHD.
  • Discussion of preclinical and clinical data for novel PET/CT tracers.

Main Results:

  • PET/CT demonstrates evolving utility in assessing valvular heart disease, especially calcific aortic stenosis and infective endocarditis.
  • Established tracers show potential, while novel tracers are under development for broader applications.
  • Advanced imaging techniques are poised to improve diagnostic accuracy and therapeutic guidance.

Conclusions:

  • PET/CT is an emerging imaging modality with significant potential to improve the diagnosis, treatment, and prognosis of valvular heart disease.
  • Continued research into radiotracer development and clinical validation is crucial for realizing the full impact of PET/CT in VHD.
  • The integration of advanced PET/CT techniques promises a transformative impact on patient care for valvular heart conditions.

More Related Videos

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

Surgery and Sample Processing for Correlative Imaging of the Murine Pulmonary Valve07:34

Surgery and Sample Processing for Correlative Imaging of the Murine Pulmonary Valve

Published on: August 5, 2021

Related Concept Videos

Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...